| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 06/08/1995 | WO1995015378A1 Antisense oligonucleotides having tumorigenicity-inhibiting activity |
| 06/08/1995 | WO1995015377A1 Plant arabinogalactan protein (agp) genes |
| 06/08/1995 | WO1995015376A2 IN VIVO ASSAYS FOR INHIBITORS OF IgE MEDIATED ALLERGIC RESPONSES |
| 06/08/1995 | WO1995015375A1 NOVEL Eph-RELATED TYROSINE KINASES, NUCLEOTIDE SEQUENCES AND METHODS OF USE |
| 06/08/1995 | WO1995015374A1 Novel metalloprotease and dna coding for the same |
| 06/08/1995 | WO1995015373A2 Inhibition of dna methyltransferase |
| 06/08/1995 | WO1995015341A1 Antibody against carcinoembryonic antigen (cea) |
| 06/08/1995 | WO1995015339A1 Antagonists to chaperonin 10 |
| 06/08/1995 | WO1995015338A1 Chaperonin 10 |
| 06/08/1995 | WO1995015333A1 Nucleosides and oligonucleotides containing boron clusters |
| 06/08/1995 | WO1995015331A1 SPECIFIC FUSION NUCLEIC ACIDS AND PROTEINS PRESENT IN HUMAN t(2;5) LYMPHOMA, METHODS OF DETECTION AND USES THEREOF |
| 06/08/1995 | WO1995015175A1 Galectin-8 and galectin-8-like proteins and dna molecules coding therefor |
| 06/08/1995 | WO1995015171A1 A 46 Kd HUMAN MILK FAT GLOBULE ANTIGEN |
| 06/08/1995 | WO1995015167A1 In utero gene therapy for fetuses |
| 06/08/1995 | WO1995015084A1 Novel apoptosis-modulating proteins, dna encoding the proteins and methods of use thereof |
| 06/08/1995 | WO1995011912A3 Biopolymer synthesis utilizing surface activated, organic polymers |
| 06/08/1995 | WO1995011309A3 A novel nuclear mitotic phosphoprotein: mitosin |
| 06/08/1995 | WO1995010034A3 A method for characterizing polymer molecules or the like |
| 06/08/1995 | WO1995002054A3 Platelet glycoprotein v gene and uses |
| 06/08/1995 | DE4424761C1 Expression cassette for continuous, stable prodn. of ribozyme |
| 06/08/1995 | CA2617836A1 Nucleosides and oligonucleotides containing boron clusters |
| 06/08/1995 | CA2178008A1 Aspergillus foetidus expression system |
| 06/08/1995 | CA2178007A1 Aspergillus expression system |
| 06/08/1995 | CA2177998A1 In utero gene therapy for fetuses |
| 06/08/1995 | CA2177991A1 A 46 kd human milk fat globule antigen |
| 06/08/1995 | CA2177988A1 Expression vector for preparing an anti-body-variable-region library |
| 06/08/1995 | CA2177957A1 Specific fusion nucleic acids and proteins present in human t(2;5) lymphoma, methods of detection and uses thereof |
| 06/08/1995 | CA2177953A1 Plant arabinogalactan protein (agp) genes |
| 06/08/1995 | CA2177832A1 Agarose plug mold and processing chamber |
| 06/08/1995 | CA2177816A1 Rna polymerase transcription factor |
| 06/08/1995 | CA2177699A1 Vector, viral protein, nucleotide sequence coding therefor and method for inhibiting immune recognition |
| 06/08/1995 | CA2177598A1 Nucleic acid sequences encoding a plant cytoplasmic protein involved in fatty acyl-coa metabolism |
| 06/08/1995 | CA2177584A1 Antibody against carcinoembryonic antigen (cea) |
| 06/08/1995 | CA2177367A1 Recombinant binding proteins and peptides |
| 06/08/1995 | CA2177252A1 Human mutator gene hmsh2 and hereditary non polyposis colorectal cancer |
| 06/08/1995 | CA2177031A1 Inhibition of dna methyltransferase |
| 06/08/1995 | CA2174972A1 Binding structures directed against the ca55.1 antigen |
| 06/08/1995 | CA2174942A1 Nucleoside analogue method |
| 06/07/1995 | EP0656425A1 Methods for enhancing nucleic acid amplification |
| 06/07/1995 | EP0656419A1 Method of highly purifying human serum albumin |
| 06/07/1995 | EP0656418A1 Superoxide dismutase and expression in microorganisms |
| 06/07/1995 | EP0656121A1 Method for diagnosing and monitoring sepsis |
| 06/07/1995 | EP0656117A1 A methodology for selecting superagonists, antagonists and superantagonists of hormones whose receptor complex includes gp 130 |
| 06/07/1995 | EP0656116A1 Methods for monitoring effectiveness of interferon therapy in individuals with hcv infections |
| 06/07/1995 | EP0656114A1 Method of determining metastatic potential of tumor cells |
| 06/07/1995 | EP0656070A1 Nucleic acid probes for bacteria of the genus legionella |
| 06/07/1995 | EP0656069A1 Inhibitors of cell proliferation, their preparation and use |
| 06/07/1995 | EP0656067A1 Screening methods for immunosuppressive agents |
| 06/07/1995 | EP0656063A1 Nucleotide sequences coding for cryptosporidium proteins, polypeptides coded by said sequences and kits for the use thereof |
| 06/07/1995 | EP0656062A1 Dorsal tissue affecting factor and compositions |
| 06/07/1995 | EP0656061A1 Novel glycoforms of soluble complement receptor 1 |
| 06/07/1995 | EP0656060A1 Androgen regulation with dna sequences of rat probasin gene |
| 06/07/1995 | EP0656059A1 Purified chitinases and use thereof |
| 06/07/1995 | EP0656056A1 Cloning and expression of the gene of the malolactic enzyme of lactococcus lactis |
| 06/07/1995 | EP0656014A1 Protein rib, a cell surface protein that confers immunity to many strains of the group b streptococcus; process for purification of the protein, reagent kit and pharmaceutical composition |
| 06/07/1995 | EP0656013A1 Peptides, analogues and mixtures thereof for detecting and eliciting antibodies to the e1 and e2 protein of rubella virus |
| 06/07/1995 | EP0656012A1 T cell epitopes of ryegrass pollen allergen |
| 06/07/1995 | EP0656007A1 Opioid receptor genes |
| 06/07/1995 | EP0655926A1 New tumor diagnosing or therapeutical probe |
| 06/07/1995 | EP0655924A1 A COMBINATION OF ANTI-erbB-2 MONOCLONAL ANTIBODIES AND METHOD OF USING |
| 06/07/1995 | EP0655890A1 Recombinant cells, dna constructs, vectors and methods for expression phytate degrading enzymes in desired ratios |
| 06/07/1995 | EP0655888A1 Production of human hemoglobin in transgenic pigs |
| 06/07/1995 | EP0603312A4 Novel gaba a? receptor with steroid binding sites. |
| 06/07/1995 | EP0578754B1 TrpR MUTATIONS EFFECTIVE IN THE EXPRESSION OF SMALL PROTEINS AND PEPTIDES |
| 06/07/1995 | EP0575462B1 A process for producing chymosin |
| 06/07/1995 | EP0462277B1 Glycoprotein of human origin, physiologically active factor comprising the same, and pharmaceutical preparation containing the same as active ingredient |
| 06/07/1995 | EP0454783B1 Site specific in-vivo activation of therapeutic drugs |
| 06/07/1995 | EP0445128B1 Proteins for fusing the sub-unit b of the choleraic toxin and heterologous antigen, and nucleic acids encoding them |
| 06/07/1995 | EP0383808B1 A gene coding for glucuronide permease |
| 06/07/1995 | EP0330655B1 Method for introduction of disease and pest resistance into plants and novel genes incorporated into plants which code therefor |
| 06/07/1995 | CN1103429A Cyclodextrin glycosyltransferases for producing ganama-cyclodextrin |
| 06/07/1995 | CN1028760C Process for preparing sequence of antidirection direction, antimessenger RNA oligonuclectides of alpha TNF |
| 06/07/1995 | CA2110764A1 Endochitinase gene induced by osmotic stress and abscisic acid isolated from the wild tomato lycopersicon chilense dun |
| 06/06/1995 | US5422275 Heterologous gene preceded by ribosomal binding site |
| 06/06/1995 | US5422274 Internal deletion mutants of soluble T4(CD4) |
| 06/06/1995 | US5422272 A genetic engineered measuring pipette comprising at least two electrodes gaped by narrow cavity with apertures, receptacles to suck the sample by reducing pressure in cavity, releasing the sample by increasing the pressure; accuracy, compact |
| 06/06/1995 | US5422268 Using Baceria |
| 06/06/1995 | US5422267 Industrial yeast comprising an integrated glucoamylase gene |
| 06/06/1995 | US5422266 Recombinant DNA vectors capable of expressing apoaequorin |
| 06/06/1995 | US5422265 Provides nucleotide sequence encoding mammalian dopamine receptor having drug dissociation properties of the human dopamine receptor d4 |
| 06/06/1995 | US5422263 DNA encoding the Trichinella spirals 53kD excretory/secretory antigen for use as immunodiagnostic reagents |
| 06/06/1995 | US5422262 Steroid 5a reductase nucleic acid segments and recombinant vectors and host cells |
| 06/06/1995 | US5422259 Culturing plants in induction medium containing 6-benzyl aminopurine |
| 06/06/1995 | US5422254 Purified DNA sequence which can be used as genetic vector |
| 06/06/1995 | US5422253 Reproducing a single strands nucleic acid, annealing one end, splitting at target position with a culture product polymerase |
| 06/06/1995 | US5422252 Simultaneous amplification of multiple targets |
| 06/06/1995 | US5422251 Hydrogen bonding a second nucleic acid strand to a first having a region of at least ten adjacent purine nucleosides; hydrogen bonding a third having at least one purine and one pyrimidine nucleoside at a pH of 6-8 |
| 06/06/1995 | US5422250 Including in the culture medium a sulfated polysaccharide |
| 06/06/1995 | US5422249 Process for the manufacture of thrombin inhibitors |
| 06/06/1995 | US5422248 Clones having nucleotide sequence from human genes which code amino acid sequences and are active in binding to membranes, solids or whole cells |
| 06/06/1995 | US5422241 A ribonuclease protective assays comprising two reagents, one reagent containing a enzyme-resistant carrier promoting the quantitative precipitation of RNA, second reagent containing a chaotropic agent deactivating nuclease |
| 06/06/1995 | US5422239 Sensitivity; purification of vital antigens |
| 06/06/1995 | US5422110 Enhanced immunogenicity using leukotoxin chimeras |
| 06/06/1995 | US5422108 Applying lysozyme which digests cell walls of microbes under acidic conditions |
| 06/06/1995 | US5422105 Use of recombinant colony stimulating factor 1 |
| 06/06/1995 | US5422104 TNF-muteins |
| 06/06/1995 | US5421839 Fermentatiion of aspergillus giganteus |
| 06/06/1995 | CA1335802C O-glycosylated igf-1 |
| 06/06/1995 | CA1335800C Synovial phospholipases |
| 06/06/1995 | CA1335799C Regeneration and transformation of cotton |